Feb 25 (Reuters) - U.S. health regulators denied approval toDynavax Technologies Inc's adult hepatitis B vaccine inits current form and asked for more data to evaluate thevaccine's safety.
The U.S. Food and Drug Administration indicated it waswilling to have discussions for a more restricted use of thevaccine Heplisav, Dynavax said in a statement.